257 related articles for article (PubMed ID: 12400015)
1. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
2. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA
Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060
[TBL] [Abstract][Full Text] [Related]
4. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
5. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
6. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
Agani F; Kirsch DG; Friedman SL; Kastan MB; Semenza GL
Cancer Res; 1997 Oct; 57(20):4474-7. PubMed ID: 9377555
[TBL] [Abstract][Full Text] [Related]
7. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
Chen AC; Guo X; Derguini F; Gudas LJ
Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
[TBL] [Abstract][Full Text] [Related]
8. Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells.
Stoica A; Saceda M; Fakhro A; Solomon HB; Fenster BD; Martin MB
J Cell Biochem; 1999 Dec; 75(4):640-51. PubMed ID: 10572247
[TBL] [Abstract][Full Text] [Related]
9. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma.
Weigel RJ; Crooks DL; Iglehart JD; deConinck EC
Cell Growth Differ; 1995 Jun; 6(6):707-11. PubMed ID: 7669725
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
Chen Y; Lee WH; Chew HK
J Cell Physiol; 1999 Dec; 181(3):385-92. PubMed ID: 10528224
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 expression is not directly responsive to estrogen.
Marks JR; Huper G; Vaughn JP; Davis PL; Norris J; McDonnell DP; Wiseman RW; Futreal PA; Iglehart JD
Oncogene; 1997 Jan; 14(1):115-21. PubMed ID: 9010238
[TBL] [Abstract][Full Text] [Related]
13. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
Graham ML; Krett NL; Miller LA; Leslie KK; Gordon DF; Wood WM; Wei LL; Horwitz KB
Cancer Res; 1990 Oct; 50(19):6208-17. PubMed ID: 2400987
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
Maor SB; Abramovitch S; Erdos MR; Brody LC; Werner H
Mol Genet Metab; 2000 Feb; 69(2):130-6. PubMed ID: 10720440
[TBL] [Abstract][Full Text] [Related]
15. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
16. Altered phenotypic characteristics of T47d human breast cancer cells after prolonged growth in estrogen-deficient medium.
Fernandez P; Wilson C; Hoivik D; Safe SH
Cell Biol Int; 1998; 22(9-10):623-33. PubMed ID: 10452832
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
18. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
19. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line.
Aprelikova O; Kuthiala A; Bessho M; Ethier S; Liu ET
Oncogene; 1996 Dec; 13(11):2487-91. PubMed ID: 8957093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]